丹参酮IIA治疗脊髓损伤修复的可能机制
Possible Mechanisms of Tanshinone IIA in the Treatment of Spinal Cord Injury Repair
DOI: 10.12677/acm.2024.1482397, PDF,    科研立项经费支持
作者: 刘春花, 艾克拜尔江·艾赛提, 艾克热木江·木合热木*:新疆医科大学第六附属医院脊柱外科,新疆 乌鲁木齐
关键词: 丹参酮IIA脊髓损伤神经再生机制Tanshinone IIA Spinal Cord Injury Nerve Regeneration Mechanism
摘要: 丹参酮IIA,也称为TanIIA,在生物体内代谢过程中扮演着多重角色,其产物能够影响多种生物化学反应。这些反应中,TanIIA有时作为辅酶参与,有时则可能促进或干扰这些反应过程,从而展现出多样的药理特性。尽管在脊髓损伤等神经系统疾病的治疗中,TanIIA已经显示出了一定的疗效,但其具体的作用机制尚未完全阐明。基于现有的研究成果,我们推测TanIIA可能通过多种药理途径,包括抗炎、抗氧化、抗细胞凋亡以及保护血管,来促进脊髓损伤后的神经细胞存活和修复。
Abstract: Tanshinone IIA, also known as TanIIA, plays multiple roles in the metabolic process of living organisms, and its products can affect a variety of biochemical reactions. In these reactions, TanIIA is sometimes involved as a coenzyme, and sometimes it may facilitate or interfere with these reaction processes, thus exhibiting diverse pharmacological properties. Although TanIIA has shown some efficacy in the treatment of neurological diseases such as spinal cord injury, its specific mechanism of action has not been fully elucidated. Based on the existing research results, we speculate that TanIIA may promote the survival and repair of nerve cells after spinal cord injury through multiple pharmacological pathways, including anti-inflammatory, antioxidant, anti-apoptosis, and vascular protection.
文章引用:刘春花, 艾克拜尔江·艾赛提, 艾克热木江·木合热木. 丹参酮IIA治疗脊髓损伤修复的可能机制[J]. 临床医学进展, 2024, 14(8): 1610-1615. https://doi.org/10.12677/acm.2024.1482397

参考文献

[1] Zhang, Y., Wang, X. and Chen, X. (2016) Tanshinone IIA: A Review of Its Pharmacological Effects and Mechanisms. Phytotherapy Research, 30, 1348-1354.
[2] Hou, Y., Liu, S., Zhang, Z., et al. (2021) Tanshinone IIA Alleviates High Glucose-Induced Endothelial Injury by Inhibiting Oxidative Stress and Apoptosis via the Nrf2/HO-1 Pathway. European Journal of Pharmacology, 899, Article 174045.
[3] Liu, Y., Ye, X., Yin, S., et al. (2020) Protective Effects of Tanshinone IIA on Osteoarthritis by Inhibiting Inflammation and Cartilage Degradation: An in Vitro and in Vivo Study. International Immunopharmacology, 80, Article 106139.
[4] Zou, L., Xue, Z., Lu, Z., et al. (2019) Tanshinone IIA Exerts an Anti-Inflammatory Effect in Mice with Sepsis by Inhibiting the TLR4/NF-κB Signaling Pathway. Molecular Medicine Reports, 20, 3049-3058.
[5] Wang, F., Zhang, Y., Yang, H., et al. (2020) Tanshinone IIA Ameliorates Amyloid Beta-Induced Neuronal Injury by Modulating Neuroinflammation through the SIRT1/NF-κB Pathway in Microglia. Frontiers in Pharmacology, 11, Article 602439.
[6] Yang, Y., Gao, Z.G., Ma, J.X., et al. (2019) Tanshinone IIA Attenuates Dextran Sulfate Sodium-Induced Colitis via Promoting Anti-Inflammatory Macrophage Polarization and Suppressing NF-κB Activation. Frontiers in Pharmacology, 10, Article 178.
[7] Huang, X.R., Liu, H.Y., We, Y., et al. (2020) Tanshinone IIA Ameliorates Diabetic Nephropathy by Inhibiting Oxidative Stress and Inflammation through Modulation of the AMPK/PGC-1α/Nrf2 Pathway. Biomedicine & Pharmacotherapy, 132, Article 110772.
[8] Li, J., Bai, T., Zhang, R., et al. (2018) Tanshinone IIA Alleviates Liver Fibrosis by Inhibiting Oxidative Stress and Apoptosis through Nrf2/HO-1 and TGF-β1/Smad2 Pathways. Chemico-Biological Interactions, 294, 110-119.
[9] Xu, M., Wang, L., Hou, Y., et al. (2021) Tanshinone IIA Exerts Beneficial Effects on Cognitive Deficits by Mitigating Oxidative Stress and Enhancing Mitochondrial Function in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimers Disease, 82, 1735-1745.
[10] Wang, X.Y., Zhao, K.F., Hao, J., et al. (2020) Tanshinone IIA Alleviates Ischemia/Reperfusion Injury in Cardiomyocytes by Modulating the ER Stress/Mitochondrial Fission Pathway. Life Sciences, 256, Article 117897.
[11] Gao, J., Liu, Y., Sun, Z., et al. (2021) Tanshinone IIA Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting the NLRP3 Inflammasome and Pyroptosis. Neural Regeneration Research, 16, 1510-1516.
[12] Li, Q., Yang, J., Yu, Z., et al. (2019) Neuroprotective Mechanism of Tanshinone IIA in Ischemic Stroke through Modulating Microglial Activation and Polarization. Frontiers in Pharmacology, 10, Article 1234.
[13] Ren, X., Guo, W., Yan, M., et al. (2020) Tanshinone IIA Mitigates Alzheimer’s Disease Pathogenesis by Attenuating Oxidative Stress and Neuroinflammation through the Nrf2 Signaling Pathway. Oxidative Medicine and Cellular Longevity, 2020, Article 5985346.
[14] Zhao, S., Yu, C., Gao, Y., et al. (2021) Tanshinone IIA Ameliorates Lipopolysaccharide-Induced Cognitive Dysfunction via Inhibition of miR-155 in Mice. Neuroscience Letters, 748, Article 135714.
[15] Zeng, Z., Huang, Y., Wang, E., et al. (2019) Tanshinone IIA Inhibits NF-κB and MAPK Signaling and Attenuates Endotoxin-Induced Acute Lung Injury in Mice. Phytomedicine, 58, Article 152874.
[16] Qian, Y., Lu, Z., Zhang, W., et al. (2019) Tanshinone IIA Improves Blood-Brain Barrier Integrity and Attenuates Inflammatory Response Induced by Cerebral Ischemia/Reperfusion in Rats. International Immunopharmacology, 66, 300-306.
[17] Zhang, S., Wang, C., Zhang, Y., et al. (2020) Tanshinone IIA Reduces Oxidative Stress and Matrix Metalloproteinase Expression by Modulating the Nrf2/ARE Pathway in Chronic Obstructive Pulmonary Disease Rats. Phytomedicine, 78, Article 153289.
[18] Zhao, Y., Wang, W., Chen, Y., et al. (2019) The Protective Effect of Tanshinone IIA on Endothelial Function in Hypertension-Induced Vascular Remodeling through the Inhibition of Oxidative Stress and Inflammation. Frontiers in Pharmacology, 10, Article 728.
[19] Feng, X., Ma, W., Zhan, Y., et al. (2020) Tanshinone IIA Ameliorates Atherosclerotic Calcification by Inhibiting Oxidative Stress and ER Stress via PI3K/Akt Pathway. Journal of Cellular and Molecular Medicine, 24, 12277-12289.
[20] Liu, J., Yang, Y., Qiu, H., et al. (2021) Tanshinone IIA Protects Human Umbilical Vein Endothelial Cells from Oxidized Low-Density Lipoprotein-Induced Oxidative Damage through the Nrf2 Pathway. Environmental Toxicology and Pharmacology, 86, Article 103686.
[21] Xu, W., Zhou, F., Shen, F., et al. (2021) Tanshinone IIA Mitigates Cerebral Ischemia/Reperfusion Injury by Regulating Autophagic Flux and Mitochondrial Function via AMPK/mTOR Signaling Pathway. International Journal of Molecular Sciences, 22, Article 7667.
[22] Li, J., Sun, Y., Zhang, L., et al. (2019) Tanshinone IIA and Its Derivatives Attenuate Hypoxia/Reoxygenation-Induced Apoptosis by Modulating the Bcl-2/Bax Ratio and Mitochondrial Permeability Transition Pore in Cardiomyocytes. Molecular Medicine Reports, 20, 1501-1508.
[23] Wang, L., Zhang, H., Yu, Y., et al. (2020) Neuroprotective Effects of Tanshinone IIA in Ischemic Stroke Models by Down-Regulating NF-κB and Pro-Inflammatory Cytokines. Brain Research, 1734, Article 146737.
[24] Zhang, H., Wen, X., Li, D., et al. (2018) Tanshinone IIA Protects against Cerebral Ischemia/Reperfusion Injury through Activation of the Nrf2/HO-1 Signaling Pathway. Experimental and Therapeutic Medicine, 15, 3634-3640.
[25] Li, C.Y., Song, Y., Li, Y., et al. (2020) Tanshinone IIA Prevents Oxidative Stress-Induced Brain Microvascular Endothelial Cell Damage through Nrf2/ARE Pathway Activation. Vascular Pharmacology, 124, Article 106619.
[26] Li, Y., Wang, B., Zhou, R., et al. (2020) Tanshinone IIA Protects against Cerebral Ischemia-Reperfusion Injury by Targeting microRNA-155-3p-Mediated Regulation of Blood-Brain Barrier Integrity. Neuroscience Letters, 735, Article 135268.
[27] Zou, Y., Yi, R., Wu, W., et al. (2019) Tanshinone IIA Protects against Hypoxia/Reoxygenation-Induced Oxidative Stress in RAW264.7 Cells via AMPK/Nrf2 Pathway. Biomedicine & Pharmacotherapy, 118, Article 109355.
[28] Zhao, X., Yu, Y., He, S., et al. (2021) Tanshinone IIA Ameliorates Cognitive Deficits Induced by Acute Cerebral Ischemia-Reperfusion through Suppression of Endoplasmic Reticulum Stress. Molecular Neurobiology, 58, 4511-4524.
[29] Zhang, Y., Li, X., Qian, Y., et al. (2019) Tanshinone IIA Inhibits Microglial Activation and Reduces Inflammatory Injury in MCAO Models through the TLR4/NF-κB Signaling Pathway. Frontiers in Pharmacology, 10, Article 1234.
[30] Chen, S., Huang, S., Wang, Q., et al. (2022) Tanshinone IIA Alleviates Brain Injury Following Subarachnoid Hemorrhage by Modulating Oxidative Stress and Neuronal Apoptosis via the PI3K/Akt Pathway. Biological Research, 55, 1-11.
[31] Chen, X.Y., Li, Y.P., Zhang, Q.S., et al. (2021) Tanshinone IIA Ameliorates Radiation-Induced Hippocampal Neuronal Injury by Reducing Oxidative Stress and Apoptosis through the Nrf2/HO-1 Signaling Pathway. International Journal of Radiation Biology, 97, 1723-1734.
[32] Wu, W., Zhao, X., Chen, W., et al. (2020) Protective Effects of Tanshinone IIA on Radiation-Induced Brain Injury in Mice by Modulating Oxidative Stress and Inflammatory Cytokines. Frontiers in Pharmacology, 11, Article 5864.
[33] Zhang, H., Sun, X., Wang, Z. and Tao, Q. (2022) Tanshinone IIA Attenuates Traumatic Spinal Cord Injury via Inhibition of Oxidative Stress-Induced Neuronal Apoptosis and Neuroinflammation through the PI3K/Akt Pathway. Neuroscience Letters, 768, Article 1363.
[34] Wang, J., Liu, S., Hou, Y., et al. (2020) Tanshinone IIA Ameliorates Diabetic Peripheral Neuropathy by Improving Mitochondrial Function and Inhibiting Oxidative Stress and Inflammation. Neural Regeneration Research, 15, 1637-1646.
[35] Guo, X., Li, F., Duan, Y., et al. (2019) Tanshinone IIA Protects against Spinal Cord Injury by Regulating the Nrf2/ARE Pathway and Reducing Oxidative Stress and Apoptosis. Journal of Molecular Neuroscience, 69, 52-59.